Medical device for the treatment of irritable bowel syndrome Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders. It is estimated to affect 10% of the general population, but prevalence rates vary widely. Women appear to be affected 1.5 to 2 times more often than men, and the prevalence appears to decrease with age. Kaleidon IBS is a medical device indicated for the treatment of irritable bowel syndrome, characterized by pain, swelling, distension and abdominal discomfort, associated or not with changes in the appearance of stool and intestinal irregularity (constipation, diarrhea or alternating both). Thanks to its protective mechanical action, Kaleidon IBS physically interacts with the intestinal mucosa, forming a mucoadhesive film that protects the mucosa from contact with irritating substances and, at the same time, helps eliminate dangerous substances by counteracting their absorption. Through a physical mechanism, it helps adsorb intestinal gases, thus reducing the typical disorders of irritable bowel syndrome. 1 Moayyedi P, et al. Canadian Association of Gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS). Journal of the Canadian Association of Gastroenterology, 2019, 2.1: 6-29 How to preserve: Store in its original packaging at room temperature, below 25°C, in a cool, dry place, away from light. Precautions and warnings: Keep out of reach of children Although there are no known adverse effects, the product is not recommended for use during pregnancy or breastfeeding, and for children under 12 years of age. In any case, consult your doctor before taking it. Do not exceed the dose of 4 tablets per day Do not take if you are allergic or hypersensitive to any component of the product. Do not use the product after the expiry date printed on the package. The expiration date refers to the product in its intact packaging, properly stored.
